Terms: = Cervical cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Clinical Outcome
4 results:
1. [Analysis of recurrence and its influencing factors in patients with cervical HSIL within 24 months after LEEP].
Chen LM; Liu L; Tao X; He Y; Guo LP; Zhang HW; Zhou XR; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2019 Aug; 54(8):534-540. PubMed ID: 31461810
[No Abstract] [Full Text] [Related]
2. Efficient detection of the V600E mutation of the BRAF gene in papillary thyroid carcinoma using multiplex allele-specific polymerase chain reaction combined with denaturing high-performance liquid chromatography.
Gong RX; Gong YP; Yang J; Wei T; Li-Ling J; Zhu JQ
Genet Mol Res; 2013 Oct; 12(4):4990-7. PubMed ID: 24301760
[TBL] [Abstract] [Full Text] [Related]
3. Expression of 14-3-3sigma in cervical squamous cell carcinomas: relationship with clinical outcome.
Holm R; Ali T; Svendsrud DH; Nesland JM; Kristensen GB; Lyng H
Oncol Rep; 2009 Jul; 22(1):11-5. PubMed ID: 19513498
[TBL] [Abstract] [Full Text] [Related]
4. Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection.
Cho NH; Kang S; Hong S; An HJ; Choi YH; Jeong GB; Choi HK
Cancer Lett; 2006 Feb; 232(2):170-8. PubMed ID: 16458113
[TBL] [Abstract] [Full Text] [Related]
